1 s blood parameters, leukocyte depletion, and bone marrow hypoplasia.

2 perplasia, extramedullary hematopoiesis, and bone marrow hypoplasia.

3 cantly reduced BCNU-induced mortality due to bone marrow hypoplasia.

4  preceded the development of neutropenia and bone-marrow hypoplasia.

5 ed as a food additive (Rux-chow), attenuated bone marrow hypoplasia, ameliorated peripheral blood pan

6 ve deletion of both PTPN1 and PTPN2 leads to bone marrow hypoplasia and lethality, while inducible de

7 a, which is characterized by immune-mediated bone marrow hypoplasia and pancytopenia, can be treated

8 n vivo, including red blood cell deficiency, bone marrow hypoplasia, and defective thymopoiesis.

9 vement in the production of red blood cells, bone marrow hypoplasia, and runting.